A Phase III Clinical Study of Minodronate Tablets in Postmenopausal Women With Osteoporosis

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
In the randomized, active-controlled, double-blinded, multicenter study, the efficacy and safety of monthly oral minodronate were examined and compared to that of weekly oral alendronate.
Epistemonikos ID: 73998390b817c1147fc2eb96a3d86a28f82c9899
First added on: May 13, 2024